Examkin

All practice questions

8270 questions

All types8,270Multiple choice4,249Multiple select325Numeric160Matching1,849Ordering1,687
Question 2321Question →

A 32-year-old man who recently immigrated from a region with high tuberculosis endemicity presents to the emergency department with a 4-week history of low-grade fevers, night sweats, productive cough, and unintended weight loss. Temperature is 37.8°C (100.0°F), blood pressure is 110/70 mmHg, pulse is 88/min, and respiratory rate is 18/min. Physical examination reveals bronchial breath sounds and crackles over the right upper lung field. A chest radiograph demonstrates a cavitary opacity in the right upper lobe. Arrange the following steps in the most appropriate chronological order for the clinical management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence is: Implement airborne precautions, followed by collecting sputum specimens, then initiating empiric multidrug therapy, and finally modifying the regimen based on susceptibility testing.
In the management of suspected active pulmonary tuberculosis, public health and infection control dictate that airborne isolation is the immediate first step. Following isolation, securing sputum for acid-fast bacilli and culture is critical to ensure high diagnostic yield and guide future therapy. Only after samples are collected should empiric four-drug therapy (isoniazid, rifampin, pyrazinamide, ethambutol) begin. Weeks later, when phenotypic drug susceptibility testing results are available, the regimen can be appropriately de-escalated or modified.

Step-by-Step Solution

1
Recognize the clinical presentation of active pulmonary tuberculosis
Identify that the patient is a high transmission risk
The triad of chronic cough, night sweats, and apical cavitary lesions strongly suggests TB.
2
Prioritize infection control
Patient is placed in a negative-pressure room
Prevents aerosolized spread of Mycobacterium tuberculosis to others in the healthcare setting.
3
Secure diagnostic workup before treatment
Sputum AFB smears and cultures obtained
Antibiotic administration can rapidly sterilize sputum or reduce yield, hindering definitive diagnosis and susceptibility testing.
4
Start empiric treatment and refine later
Patient is started on RIPE therapy, which is narrowed weeks later
Early empiric treatment is necessary for patient recovery, while final narrowing prevents antibiotic resistance.

Key Concept

The chronological management of active pulmonary tuberculosis emphasizes immediate airborne isolation, followed by diagnostic sampling prior to the initiation of empiric antimicrobial therapy.
Estimated Time:1m 0s
Question 2322Question →

During routine well-child visits, developmental surveillance is a critical component of preventive care. Arrange the following communication and language milestones in the correct chronological order of their typical emergence in a healthy developing child, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological progression of language milestones is: cooing (2 months), babbling (6 months), saying 'mama' or 'dada' specifically (12 months), combining words into two-word phrases (24 months), and telling a simple story (4 years).
Language development follows a predictable, chronological pattern. It starts with simple vowel sounds (cooing at 2 months), progresses to consonant-vowel combinations (babbling at 6 months), meaningful single words ('mama/dada' specifically at 12 months), simple word combinations (two-word phrases at 24 months), and ultimately advances to complex narrative skills (telling a story at 4 years).

Step-by-Step Solution

1
Identify the earliest infant vocalization milestone.
Cooing is the first milestone, emerging at 2 months.
Infants begin producing simple vowel sounds before they develop the motor control to articulate consonants.
2
Identify the next stage of vocal development.
Babbling with consonant-vowel sounds emerges at 6 months.
As infants gain better control over their lips and tongue, they add basic consonants to their vocalizations.
3
Determine when words are first used with specific meaning.
Saying 'mama' or 'dada' specifically to the parents occurs at 12 months.
Although non-specific repetition happens earlier (around 9 months), assigning meaning and directing the words correctly is a 12-month milestone.
4
Identify the emergence of early word combinations.
Combining words into two-word phrases occurs at 24 months.
At 2 years of age, toddlers typically experience a language explosion, linking their growing vocabulary to form basic sentences.
5
Identify the most advanced language milestone in the list.
Telling a simple story occurs at 4 years.
This stage requires advanced vocabulary, grammatical structure, and narrative understanding.

Key Concept

Chronological progression of normal language and communication milestones in pediatric development.
Estimated Time:1m 0s
Question 2323Question →

A 26-year-old man comes to the office due to a 5-day history of right knee swelling and pain. He also reports a mild burning sensation during urination and bilateral eye redness that started around the same time. He has no significant past medical history and takes no medications. Three weeks ago, he had a 4-day episode of abdominal cramps and watery diarrhea that resolved without medical treatment. His temperature is 37.6°C (99.7°F), blood pressure is 120/80 mm Hg, and pulse is 82/min. Physical examination reveals bilateral conjunctival injection. The right knee is swollen, warm, and tender to palpation with a moderate effusion. Arthrocentesis is performed. Synovial fluid analysis shows a leukocyte count of 24,000/mm³ with a negative Gram stain and no crystals. Which of the following is the most appropriate initial management for this patient's condition?

Show answer & explanation

Answer: Oral ibuprofen

Answer

The correct answer is oral ibuprofen, as nonsteroidal anti-inflammatory drugs are the preferred first-line treatment for reactive arthritis.
This patient's presentation of asymmetric oligoarthritis, conjunctivitis, and urethritis following a recent gastrointestinal illness is the classic triad of reactive arthritis. Reactive arthritis is a seronegative spondyloarthropathy that typically develops 1 to 4 weeks after a gastrointestinal (e.g., Salmonella, Shigella, Campylobacter) or genitourinary (e.g., Chlamydia) infection. Synovial fluid analysis characteristically reveals an inflammatory effusion (often 2,000 to 50,000 leukocytes/mm³) with a negative Gram stain and no crystals, confirming a sterile inflammatory process. The initial and most effective treatment for the acute joint inflammation in reactive arthritis is a nonsteroidal anti-inflammatory drug (NSAID), such as oral ibuprofen.

Step-by-Step Solution

1
Identify the patient's clinical syndrome based on the history and physical examination.
The combination of asymmetric oligoarthritis, conjunctivitis, and urethritis following a recent diarrheal illness is classic for reactive arthritis.
To establish the underlying diagnosis before determining the appropriate treatment.
2
Evaluate the synovial fluid analysis results.
The synovial fluid shows an inflammatory leukocyte count (24,000/mm³) but is sterile (negative Gram stain) and free of crystals.
To safely rule out septic arthritis and crystal arthropathies, which require entirely different management.
3
Select the most appropriate initial therapy for the diagnosed condition.
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen are selected.
NSAIDs are the first-line symptomatic treatment for the immune-mediated joint inflammation seen in reactive arthritis.

Key Concept

The classic presentation of reactive arthritis (arthritis, urethritis, and conjunctivitis following a gastrointestinal or genitourinary infection) and its initial management with nonsteroidal anti-inflammatory drugs.
Question 2324Question →

A mother brings her daughter, aged 4 years and 2 months, to the pediatric clinic for a health maintenance visit. The child was diagnosed with minimal change disease one month ago and has been taking daily oral prednisone at a dose of 2 mg/kg for the past 24 days. Her vital signs are within normal limits for her age, and physical examination reveals mild facial puffiness but is otherwise unremarkable. The mother expresses concern regarding her daughter's development, noting that the child can hop on one foot and copy a cross, but is unable to skip or draw a person with more than three body parts. A review of the electronic health record shows the patient received all recommended infant and toddler immunizations up to 18 months of age, but she has not yet received any of her preschool vaccine boosters. Which of the following is the most appropriate management regarding this patient's immunizations and development?

Show answer & explanation

Answer: Provide diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines only; offer reassurance about milestones

Answer

Provide diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines only; offer reassurance about milestones
This patient requires her preschool booster vaccines but is currently significantly immunosuppressed due to high-dose systemic corticosteroid therapy (prednisone at 2 mg/kg/day for >14 days). In this state, live-attenuated vaccines (such as measles-mumps-rubella and varicella) are strictly contraindicated due to the risk of severe, disseminated vaccine-strain infection. However, inactivated vaccines (such as diphtheria-tetanus-acellular pertussis and inactivated poliovirus) are safe and should be administered on schedule. Furthermore, the child's development is entirely age-appropriate. At 4 years of age, normal milestones include hopping on one foot, copying a cross, and drawing a person with 3 body parts. Skipping, copying a triangle, and drawing a person with 6 body parts are expected at 5 years of age. Therefore, the mother should be reassured, and no developmental referral is needed.

Step-by-Step Solution

1
Evaluate the patient's immune status based on her medication regimen.
The patient is taking prednisone at 2 mg/kg/day for over 14 days, which qualifies as highly immunosuppressive corticosteroid therapy.
To determine whether she has any immune-related contraindications to her scheduled preschool vaccines.
2
Determine which preschool vaccines are safe to administer.
Inactivated vaccines (DTaP, IPV) are safe to administer, while live-attenuated vaccines (MMR, varicella) are strictly contraindicated and must be deferred until at least one month after steroid cessation.
Live vaccines can cause fatal disseminated infections in immunocompromised hosts, whereas inactivated vaccines pose no such risk.
3
Assess the patient's developmental milestones relative to her chronological age.
The child can hop and copy a cross (expected 4-year milestones) but cannot skip or draw a 6-part person (expected 5-year milestones). This is perfectly normal for a 4-year-old.
To address the mother's concern and decide if a neurodevelopmental referral is clinically indicated.

Key Concept

High-dose systemic corticosteroids (2 mg/kg/day or 20 mg/day of prednisone for 14 or more days) are a contraindication for live-attenuated vaccines, but inactivated vaccines may be safely administered. Skipping and drawing a 6-part person are 5-year milestones, not 4-year milestones.
Question 2325Question →

A 42-year-old woman is evaluated for progressive central weight gain, severe fatigue, easy bruising, and proximal muscle weakness over the past 8 months. Examination reveals facial plethora, prominent supraclavicular fat pads, and wide violaceous striae on the lower abdomen. Her blood pressure is 158/96 mm Hg. The physician suspects Cushing syndrome. Assuming the evaluation ultimately reveals an ACTH-dependent etiology but initial localization imaging is equivocal, arrange the following diagnostic steps in the most appropriate sequential order, from initial evaluation to definitive confirmation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order for evaluating suspected Cushing syndrome is: 1) Review for exogenous glucocorticoids, 2) Biochemical confirmation of hypercortisolism, 3) Measurement of plasma ACTH, 4) MRI of the pituitary, and 5) Inferior petrosal sinus sampling (IPSS).
The evaluation of Cushing syndrome follows a strict chronological hierarchy to maximize diagnostic accuracy and avoid the pitfalls of incidentalomas. The most common cause of Cushingoid features is exogenous glucocorticoid use, which must be ruled out by a careful medication history before any biochemical testing. Once excluded, endogenous hypercortisolism must be definitively established using at least one first-line test (e.g., 24-hour urine free cortisol, 1-mg overnight dexamethasone suppression test, or late-night salivary cortisol). Only after hypercortisolism is confirmed should a plasma ACTH level be drawn to differentiate ACTH-dependent (pituitary or ectopic) from ACTH-independent (adrenal) causes. For ACTH-dependent disease, an MRI of the pituitary is the initial localizing step because Cushing disease (pituitary adenoma) is the most common etiology. However, because small pituitary incidentalomas are common and small corticotroph adenomas can be missed on MRI, an equivocal scan (e.g., a normal MRI or a lesion <6 mm) requires inferior petrosal sinus sampling (IPSS) to definitively differentiate a pituitary source from an occult ectopic ACTH-secreting tumor.

Step-by-Step Solution

1
Exclude exogenous glucocorticoid use.
Prevents unnecessary diagnostic workup.
Exogenous administration (even via topical or inhaled routes) is the most common cause of Cushing syndrome.
2
Perform initial biochemical screening for hypercortisolism.
Confirms the presence of endogenous hypercortisolism.
Establishing the diagnosis biochemically is required before attempting to localize the source, as non-diagnostic testing can lead to false-positive incidentalomas.
3
Measure plasma ACTH concentration.
Categorizes the hypercortisolism as ACTH-dependent or ACTH-independent.
A suppressed ACTH indicates an adrenal source (requiring adrenal imaging), while a normal or elevated ACTH indicates a pituitary or ectopic source (requiring pituitary imaging).
4
Perform a pituitary MRI.
Identifies potential pituitary corticotroph adenomas.
Since the majority of ACTH-dependent Cushing syndrome is caused by Cushing disease (pituitary adenoma), dedicated imaging of the sella turcica is the first localization step.
5
Perform inferior petrosal sinus sampling (IPSS).
Differentiates between pituitary and ectopic ACTH production.
In cases of ACTH-dependent Cushing syndrome where the pituitary MRI is equivocal or shows a lesion <6 mm, IPSS is the gold standard to confirm a central source and guide surgical management.

Key Concept

The sequential diagnostic algorithm for Cushing syndrome progresses from excluding exogenous causes to confirming endogenous hypercortisolism, determining ACTH dependence, and finally localizing the source with imaging and invasive sampling.
Estimated Time:2m 0s
Question 2326Question →

A 72-year-old man with a history of metastatic prostate cancer is brought to the emergency department with a 2-day history of progressively worsening lower back pain, bilateral leg weakness, and new-onset urinary incontinence. Neurologic examination reveals decreased sensation to pinprick below the umbilicus, 2/5 motor strength in both lower extremities, and hyperreflexia in the knees and ankles. Anal sphincter tone is decreased. You suspect malignant epidural spinal cord compression. Arrange the following management steps in the most appropriate chronological order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first administer intravenous dexamethasone, then obtain an MRI of the spine, followed by consulting neurosurgery or radiation oncology, and finally initiating definitive surgical decompression or radiation therapy.
Malignant epidural spinal cord compression (MESCC) is an oncologic emergency. The first and most critical step in management is the immediate administration of high-dose intravenous glucocorticoids (e.g., dexamethasone) based purely on clinical suspicion. This reduces peritumoral edema, relieves pressure on the spinal cord, and preserves neurologic function. Once steroids are given, an urgent MRI of the entire spine is obtained to confirm the diagnosis and delineate the extent of the disease. Following imaging, surgical or radiation oncology specialists are consulted to determine the best definitive treatment, which is then initiated.

Step-by-Step Solution

1
Administer high-dose intravenous dexamethasone
Reduces spinal cord edema and pressure
Prevents permanent neurologic damage while waiting for confirmatory imaging.
2
Obtain an urgent MRI of the entire spine
Confirms the diagnosis and level of compression
Gold standard imaging is required to map the exact location of the lesion before surgery or radiation.
3
Consult neurosurgery or radiation oncology
Determines the optimal definitive management plan
Specialist input is necessary to decide between surgical and radiotherapeutic options.
4
Initiate definitive surgical decompression or radiation therapy
Provides long-term relief of cord compression
Treats the underlying malignant lesion causing the mechanical compression.

Key Concept

Malignant epidural spinal cord compression is an oncologic emergency requiring empiric high-dose glucocorticoids immediately upon clinical suspicion, prior to any confirmatory imaging.
Question 2327Question →

An emergency department physician evaluates a 71-year-old man for progressively blurred vision, recurrent severe epistaxis, and confusion over the past two weeks. On physical examination, the patient appears lethargic. Fundoscopy reveals tortuous, engorged retinal veins with a classic 'sausage-link' appearance alongside bilateral retinal hemorrhages. Initial laboratory studies show:

Laboratory ParameterValue
Hemoglobin9.2 g/dL
Total serum protein10.8 g/dL
Albumin3.4 g/dL

Subsequent serum protein electrophoresis identifies a prominent monoclonal spike in the gamma-globulin region. His serum viscosity is markedly elevated at 5.8 centipoise (normal: 1.4-1.8).

Arrange the following steps in the most appropriate and safe chronological sequence for the management of this patient:

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first draw diagnostic blood tests, followed by emergent therapeutic plasmapheresis to stabilize the patient, then perform a bone marrow biopsy for definitive tissue diagnosis, and finally initiate systemic chemoimmunotherapy.
The correct sequence prioritizes securing diagnostic evidence before altering it, immediately managing the life-threatening emergency, confirming the underlying pathology safely, and finally treating the root cause. First, blood must be drawn for immunofixation to capture accurate baseline immunoglobulin levels. Second, emergent plasmapheresis is performed to rapidly reverse the life-threatening hyperviscosity syndrome. Third, after the patient is stabilized and bleeding risk is reduced, an invasive bone marrow biopsy is safely obtained for definitive tissue diagnosis. Finally, systemic chemoimmunotherapy is initiated to treat the underlying Waldenström macroglobulinemia, ensuring this occurs post-plasmapheresis to avoid a dangerous rituximab-induced IgM flare.

Step-by-Step Solution

1
Draw peripheral blood for immunofixation electrophoresis and quantitative immunoglobulins
Establishes baseline immunoglobulin levels and characterizes the monoclonal protein as IgM.
Must be performed prior to plasma exchange; otherwise, the therapeutic removal of immunoglobulins will artificially lower the diagnostic levels and obscure the true nature of the gammopathy.
2
Perform emergent therapeutic plasmapheresis
Rapidly clears high-molecular-weight IgM pentamers from the intravascular space, decreasing serum viscosity.
Hyperviscosity syndrome with end-organ damage (confusion, retinal hemorrhages) is an emergency requiring immediate mechanical removal of the offending protein to prevent irreversible ischemic strokes or coma.
3
Obtain a bone marrow aspiration and biopsy
Provides tissue to definitively identify a lymphoplasmacytic cellular infiltrate.
An invasive biopsy is safely performed after the patient is stabilized and hyperviscosity-induced platelet dysfunction is corrected. It is required for the definitive diagnosis of Waldenström macroglobulinemia.
4
Initiate systemic chemoimmunotherapy (e.g., rituximab and bendamustine)
Targets the underlying malignant clonal B-cells to provide long-term disease control.
Definitive therapy is started after pathologic confirmation. Importantly, administering rituximab prior to plasmapheresis is contraindicated here, as it can trigger a paradoxical 'IgM flare' that sharply increases viscosity.

Key Concept

Waldenström Macroglobulinemia and Hyperviscosity Syndrome Management
Estimated Time:2m 0s
Question 2328Question →

Match the following classic clinical descriptions of benign neonatal skin findings with their most likely diagnoses.

Click a left item, then click its matching right item

Items

Erythematous macules with central yellow-white papules on the trunk and extremities, showing prominent eosinophils on microscopic evaluation.
Firm, pearly-white papules on the nose and cheeks of a newborn, consisting of superficial epidermal keratin cysts.
Flat, blue-gray macular patches with poorly defined margins, typically found on the lumbosacral region of dark-skinned infants.
Vesiculopustular rash without surrounding erythema that quickly ruptures, leaving hyperpigmented macules and showing neutrophils on microscopy.

Matches

Show answer & explanation

Answer

The correct matches are: Erythematous macules with eosinophils match Erythema toxicum neonatorum. Pearly-white keratin cysts match Milia. Blue-gray sacral macules match Congenital dermal melanocytosis. Vesiculopustules without erythema showing neutrophils match Transient neonatal pustular melanosis.
Each clinical description maps uniquely to a classic, benign neonatal skin condition. Recognizing these patterns is essential to avoid unnecessary testing or treatments and to provide appropriate reassurance to parents.

Step-by-Step Solution

1
Analyze the microscopic contents and visual appearance of the vesicular/pustular rashes.
Eosinophils identify erythema toxicum neonatorum, while neutrophils identify transient neonatal pustular melanosis. Keratin identifies milia.
Differentiating these benign rashes often relies on the cellular contents of the lesions.
2
Evaluate the non-pustular, pigmented lesions based on color and location.
Blue-gray pigmentation on the sacrum perfectly describes congenital dermal melanocytosis.
Identifying characteristic pigmentation patterns prevents misdiagnosing benign lesions as child abuse (bruising).

Key Concept

Benign Neonatal Dermatological Findings
Question 2329Question →

Match each autoantibody profile to the rheumatologic condition with which it is most specifically associated.

Click a left item, then click its matching right item

Items

Anti-Scl-70 (anti-topoisomerase I) antibodies
Anti-Jo-1 (anti-histidyl-tRNA synthetase) antibodies
Anti-U1 ribonucleoprotein (anti-U1 RNP) antibodies
Anti-cyclic citrullinated peptide (anti-CCP) antibodies

Matches

Show answer & explanation

Answer

Anti-Scl-70 pairs with Diffuse cutaneous systemic sclerosis; Anti-Jo-1 pairs with Polymyositis / Dermatomyositis; Anti-U1 RNP pairs with Mixed connective tissue disease; Anti-CCP pairs with Rheumatoid arthritis.
Each autoantibody has a distinct clinical association that aids in differentiating various rheumatologic diseases. Anti-Scl-70 is linked to diffuse systemic sclerosis. Anti-Jo-1 is tied to inflammatory myopathies (polymyositis/dermatomyositis). Anti-U1 RNP defines mixed connective tissue disease. Anti-CCP is a highly specific marker for rheumatoid arthritis.

Step-by-Step Solution

1
Analyze the first antibody, Anti-Scl-70.
It pairs with diffuse cutaneous systemic sclerosis.
Anti-Scl-70 (anti-topoisomerase I) is a classic marker for the diffuse variant of systemic sclerosis.
2
Analyze the second antibody, Anti-Jo-1.
It pairs with polymyositis / dermatomyositis.
Anti-Jo-1 is an anti-synthetase antibody strongly associated with inflammatory myopathies.
3
Analyze the third antibody, Anti-U1 RNP.
It pairs with mixed connective tissue disease.
The defining serologic feature of mixed connective tissue disease is the presence of high-titer anti-U1 RNP antibodies.
4
Analyze the fourth antibody, Anti-CCP.
It pairs with rheumatoid arthritis.
Anti-CCP antibodies have very high specificity for rheumatoid arthritis and often appear before clinical symptoms.

Key Concept

Specific autoantibody profiles in rheumatologic conditions
Question 2330Question →

A pediatric clinic is creating a quick-reference chart for residents to use during routine well-child evaluations. The chart aims to integrate various developmental domains across the first three years of life. Arrange the following key developmental milestones in their correct chronological sequence of expected acquisition, starting with the earliest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Demonstrates a social smile (2 months) -> Sits momentarily without support (6 months) -> Pulls to a standing position (9 months) -> Uses a mature pincer grasp (10-12 months) -> Combines words into two-word phrases (24 months) -> Pedals a tricycle (36 months).
Normal pediatric development follows a predictable chronological sequence across multiple domains. The social smile is an early personal-social milestone typically appearing by 2 months of age. Postural control develops cephalocaudally; sitting without support emerges around 6 months, followed by the ability to pull to a standing position at 9 months. Fine motor skills concurrently progress, with the mature pincer grasp (using the pads of the index finger and thumb) developing by 10 to 12 months. Language and advanced motor skills emerge later, with two-word phrases expected by 24 months (2 years) and pedaling a tricycle by 36 months (3 years).

Step-by-Step Solution

1
Identify the earliest milestone in infancy.
Demonstrates a social smile
The social smile is one of the earliest reliable social milestones, expected at 2 months of age.
2
Sequence the remaining milestones occurring in the first year of life.
Sits momentarily without support, then Pulls to a standing position, then Uses a mature pincer grasp.
Gross motor development progresses cephalocaudally. Sitting unsupported occurs around 6 months, pulling to a stand occurs around 9 months, and the fine motor mature pincer grasp develops around 10 to 12 months.
3
Sequence the milestones occurring in early childhood (2-3 years).
Combines words into two-word phrases, then Pedals a tricycle.
Two-word phrases typically emerge at 2 years (24 months), and pedaling a tricycle is classically achieved at 3 years (36 months).

Key Concept

Chronological acquisition of key developmental milestones
Estimated Time:1m 0s
Question 2331Question →

A 65-year-old man presents to the preoperative clinic for medical clearance prior to an elective open abdominal aortic aneurysm (AAA) repair. His medical history is significant for hypertension, type 2 diabetes mellitus, and stable angina. He reports that he lives a sedentary lifestyle and experiences mild chest tightness when walking up a single flight of stairs, prompting him to stop and rest. His current medications include lisinopril, metformin, atorvastatin, and aspirin. His vital signs are within normal limits, and his physical examination is unremarkable. His resting electrocardiogram shows normal sinus rhythm without acute ischemic changes.

Arrange the following steps for the preoperative cardiac risk evaluation and management of this patient in the correct algorithmic sequence according to current standard guidelines.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence requires first calculating the clinical/surgical risk of MACE, followed by assessing the patient's functional capacity (METs). Because functional capacity is poor, the next step is noninvasive pharmacologic stress testing, and finally invasive coronary angiography if the stress test demonstrates severe ischemia.
The standard evaluation of preoperative cardiac risk follows a strict step-wise algorithm. First, emergency surgery and acute coronary syndrome are ruled out. Next, baseline risk of Major Adverse Cardiac Events (MACE) is estimated using a tool like the Revised Cardiac Risk Index (RCRI). If the risk is elevated (>1%>1\%), functional capacity is assessed. If functional capacity is poor (<4<4 METs), noninvasive pharmacologic stress testing is indicated. Finally, if the stress test is markedly abnormal, invasive coronary angiography is pursued.

Step-by-Step Solution

1
Determine the baseline perioperative risk of major adverse cardiac events (MACE).
The patient is undergoing high-risk vascular surgery (AAA repair) and has multiple clinical risk factors (diabetes, angina), placing him in an elevated risk category (>1%>1\%).
Initial risk stratification determines whether a patient can proceed directly to surgery (if low risk) or requires further evaluation (if elevated risk).
2
Evaluate the patient's functional capacity in metabolic equivalents (METs).
The patient experiences chest tightness walking up a single flight of stairs, indicating a functional capacity of <4<4 METs.
Patients with an elevated clinical risk but excellent or good functional capacity (≥4\ge 4 METs) can safely proceed to surgery without further cardiac testing. Poor functional capacity necessitates the next step in the algorithm.
3
Order noninvasive pharmacologic stress testing.
A pharmacologic stress test is arranged to quantify ischemic burden.
In a patient with elevated risk and poor functional capacity (<4<4 METs) undergoing high-risk surgery, noninvasive stress testing is recommended to evaluate if changes in perioperative management are required.
4
Evaluate the stress test results to determine the need for invasive angiography.
Coronary angiography is considered as a follow-up intervention.
If the noninvasive test shows extensive reversible ischemia, invasive angiography and potential revascularization are indicated before the elective AAA repair to reduce perioperative mortality.

Key Concept

Preoperative cardiac risk assessment for noncardiac surgery relies on a stepwise algorithm: estimating MACE risk, evaluating functional capacity (METs), and utilizing noninvasive stress testing if the patient has elevated risk combined with poor functional capacity (<4<4 METs).
Estimated Time:1m 30s
Question 2332Question →

A first-year surgical resident is assisting in the repair of a complex lower extremity laceration in the emergency department. The patient is known to have untreated HIV with a recent viral load of 120,000120,000 copies/mL. During the procedure, the resident accidentally sustains a deep percutaneous puncture wound to their left index finger with a hollow-bore needle that is visibly contaminated with the patient's blood. The resident immediately stops assisting and removes their surgical gloves.

Arrange the following steps in the most appropriate chronological sequence for the management of this occupational exposure.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing an occupational percutaneous HIV exposure is to first decontaminate the wound, followed by reporting to occupational health, obtaining baseline serologies, rapidly initiating a three-drug antiretroviral prophylaxis regimen, and finally conducting long-term serological follow-up.
This sequence strictly aligns with CDC guidelines for occupational exposure to bloodborne pathogens. Immediate local wound care (washing copiously with soap and water) is the absolute first priority to mechanically reduce the inoculum. Caustic agents or squeezing the wound to induce bleeding are not recommended. Next, reporting the incident allows occupational health to coordinate the formal exposure protocol. Baseline serologies must then be drawn from the healthcare worker to establish their pre-exposure serostatus. Crucially, a three-drug post-exposure prophylaxis (PEP) regimen must be initiated immediately after blood is drawn, ideally within 1-2 hours, without waiting for those baseline laboratory results to return. Finally, because PEP is not universally effective, the exposed worker requires serial follow-up testing at 6 weeks, 12 weeks, and 6 months to monitor for late seroconversion.

Step-by-Step Solution

1
Wash the wound
Decreased viral bioburden
Immediate mechanical removal of the pathogen reduces the total inoculum and subsequent transmission risk.
2
Report to occupational health
Formal risk assessment and protocol activation
Institutional protocols require documentation and authorized personnel to facilitate appropriate testing and medication dispensing.
3
Draw baseline laboratory tests
Established pre-exposure serostatus
Essential to determine if the healthcare worker was already infected prior to this specific occupational exposure.
4
Initiate a 3-drug PEP regimen
Systemic antiretroviral blockade
Early initiation (within 1-2 hours) maximizes the prevention of viral replication and systemic integration.
5
Schedule serial follow-up testing
Long-term serological monitoring
PEP does not guarantee prevention; delayed seroconversion must be monitored over a 6-month window.

Key Concept

Management of occupational HIV exposure follows a strict protocol: immediate local decontamination, reporting, baseline serological testing, rapid initiation of a 3-drug PEP regimen (ideally within 1-2 hours, without waiting for lab results), and longitudinal follow-up.
Estimated Time:1m 30s
Question 2333Question →

A 12-month-old boy is brought to the clinic for a routine well-child visit. His mother reports that he pulls to a stand and cruises along furniture, but she is concerned because he is not yet walking independently. He uses a neat pincer grasp to pick up small pieces of food. He says "mama" and "dada" specifically to his parents but uses no other recognizable words. He plays peek-a-boo and waves goodbye. The boy is due for his routine 12-month immunizations, which include the live-attenuated measles-mumps-rubella (MMR) and varicella vaccines. However, his 6-year-old sister recently underwent a hematopoietic stem cell transplant for acute myeloid leukemia and is currently severely immunocompromised. The mother asks if it is safe for the boy to receive his scheduled vaccines given his sister's condition. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassure the mother regarding his development and administer the MMR and varicella vaccines.

Answer

Reassure the mother regarding his development and administer the MMR and varicella vaccines.
The correct action is to reassure the mother that her child's development is perfectly on track and to administer the scheduled MMR and varicella vaccines. At 12 months of age, normal milestones include cruising, using a neat pincer grasp, saying 'mama' and 'dada' specifically, and playing social games like peek-a-boo. The lack of independent walking at exactly 12 months is a normal variant and does not require a developmental referral. Regarding immunizations, the Centers for Disease Control and Prevention (CDC) strongly recommends that healthy individuals who live with immunocompromised patients receive all routine vaccinations, including live-attenuated vaccines like MMR and varicella. This 'cocooning' strategy creates a ring of immunity around the vulnerable patient, protecting them from wild-type pathogens which cause significantly more severe disease than vaccine-strain viruses. The MMR vaccine viruses are not transmitted to contacts. While the varicella vaccine virus can rarely be transmitted if the vaccinee develops a localized vesicular rash (occurring in about 5% of cases), the recommendation remains to vaccinate; the family should simply be advised to separate the infant from the sister only if such a rash appears.

Step-by-Step Solution

1
Evaluate the child's developmental milestones for a 12-month-old infant.
Gross motor (pulls to stand, cruises), fine motor (neat pincer grasp), language ('mama'/'dada' specifically), and social (peek-a-boo, waving) are all age-appropriate. Not walking independently is normal at this age.
To determine if a developmental referral is warranted.
2
Assess the contraindications for administering live-attenuated vaccines to a patient with an immunocompromised household contact.
Healthy household contacts of immunocompromised individuals should receive routine live-attenuated vaccines (MMR, Varicella, Rotavirus) to prevent wild-type infection transmission.
To determine the safest immunization plan that protects both the patient and the severely immunocompromised sibling.
3
Synthesize the findings to select the best management strategy.
Reassure the mother about the normal milestones and proceed with administering both the MMR and varicella vaccines.
This strategy provides appropriate anticipatory guidance and adheres to CDC/AAP immunization guidelines for 'cocooning' immunocompromised individuals.

Key Concept

Healthy household contacts of severely immunocompromised patients should receive all routine age-appropriate live-attenuated vaccines (including MMR and varicella) to protect the immunocompromised family member from dangerous wild-type infections. Furthermore, independent walking is a 12- to 15-month milestone, and its absence at exactly 12 months is normal.
Estimated Time:1m 30s
Question 2334Question →

Match each autoantibody to its most characteristic associated rheumatologic condition or clinical feature.

Click a left item, then click its matching right item

Items

Anti-cyclic citrullinated peptide (anti-CCP) antibodies
Anti-double-stranded DNA (anti-dsDNA) antibodies
Anti-centromere antibodies
Anti-Scl-70 (anti-topoisomerase I) antibodies

Matches

Show answer & explanation

Answer

The correct matches are: Anti-CCP with Rheumatoid Arthritis; Anti-dsDNA with Systemic Lupus Erythematosus; Anti-centromere with Limited Cutaneous Systemic Sclerosis; and Anti-Scl-70 with Diffuse Cutaneous Systemic Sclerosis.
Autoantibodies serve as crucial diagnostic and prognostic markers in rheumatology. Anti-CCP is highly specific for Rheumatoid Arthritis. Anti-dsDNA is specific for SLE and tracks disease activity. Anti-centromere and anti-Scl-70 help differentiate between limited and diffuse cutaneous systemic sclerosis, respectively, with each carrying distinct clinical features and visceral risks.

Step-by-Step Solution

1
Identify the disease association for anti-CCP antibodies.
Matches with Rheumatoid Arthritis.
Anti-CCP is the most specific serological marker for RA.
2
Identify the disease association for anti-dsDNA antibodies.
Matches with Systemic Lupus Erythematosus.
Anti-dsDNA is specific to SLE and its titer correlates with disease flares and renal involvement.
3
Identify the disease association for anti-centromere antibodies.
Matches with Limited Cutaneous Systemic Sclerosis.
It is the defining serological feature of limited systemic sclerosis (CREST syndrome).
4
Identify the disease association for anti-Scl-70 antibodies.
Matches with Diffuse Cutaneous Systemic Sclerosis.
It distinguishes the diffuse form of systemic sclerosis from the limited form and predicts a higher risk of interstitial lung disease.

Key Concept

Clinical utility of specific autoantibodies in the diagnosis and prognostication of systemic autoimmune diseases.
Question 2335Question →

An 18-month-old toddler is evaluated at a primary care clinic after relocating from another state. The parents note that he has had nasal congestion and a mild cough for the past 48 hours. His temperature is 37.8°C (100.0°F), pulse is 110/min, and respirations are 24/min. Physical examination demonstrates clear rhinorrhea and a mildly erythematous posterior oropharynx. Auscultation reveals clear breath sounds bilaterally without wheezing or crackles. He is playful, runs around the examination room, scribbles on a piece of paper, and uses approximately 15 different words. Review of his medical record indicates that his last immunizations were administered at the age of 6 months. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administer all overdue age-appropriate vaccines today

Answer

Administer all overdue age-appropriate vaccines today
The correct course of action is to administer all overdue age-appropriate vaccines simultaneously. A cornerstone of pediatric preventive care is minimizing missed opportunities for immunization. According to standard guidelines, mild acute illness (e.g., upper respiratory tract infection, mild diarrhea, otitis media), with or without a low-grade fever, is a false contraindication to vaccination. Because this patient is significantly behind on his immunization schedule (last vaccinated at 6 months of age), it is crucial to update his vaccines today. Both inactivated and live-attenuated vaccines can and should be administered safely in this clinical scenario.

Step-by-Step Solution

1
Evaluate the patient's current clinical presentation to identify any true contraindications to vaccination.
The patient has a mild upper respiratory tract infection with a low-grade fever.
Moderate to severe acute illness (with or without fever) is a valid precaution for vaccination, but mild illness is a false contraindication.
2
Assess the patient's developmental milestones to rule out any underlying neurological or developmental conditions.
The patient's motor skills (running, scribbling) and language skills (15 words) are completely normal for an 18-month-old.
Accurately identifying normal development prevents unnecessary specialist referrals that could distract from required preventive care.
3
Determine the appropriate immunization strategy based on the patient's age and previous vaccine history.
The patient is overdue for multiple vaccines since his last visit was at 6 months of age. All eligible vaccines should be given simultaneously.
Catch-up vaccination should be prioritized in healthy children to prevent missed opportunities for immunization, regardless of mild concurrent illness.

Key Concept

Mild acute illness, with or without low-grade fever, is a false contraindication to vaccination; all age-appropriate vaccines (both inactivated and live-attenuated) should be administered without delay.
Estimated Time:1m 0s
Question 2336Question →

During morning rounds, the internal medicine team evaluates a patient who was recently admitted for high-grade non-Hodgkin lymphoma. The patient, a 4848-year-old male, started induction chemotherapy 4848 hours ago. The nursing staff reports that he acutely developed profound nausea, intense muscle cramping, and palpitations over the last hour. Vital signs show a temperature of 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure of 100/60100/60 mm Hg, an irregular pulse of 118118/min, and a respiratory rate of 2020/min. He appears visibly lethargic. Cardiac auscultation reveals an irregular rhythm without murmurs, and the lungs are clear to auscultation. A stat electrocardiogram (ECG) is obtained, which reveals tall, peaked T waves and a prolonged PR interval. Laboratory analysis yields the following results:

TestResult
Potassium6.86.8 mEq/L
Calcium6.86.8 mg/dL
Phosphorus6.56.5 mg/dL
Uric acid14.214.2 mg/dL
Blood urea nitrogen4545 mg/dL
Creatinine2.82.8 mg/dL

Based on the clinical presentation and laboratory findings, which of the following is the most appropriate initial step in the management of this patient?

Show answer & explanation

Answer: Administration of calcium gluconate via intravenous infusion

Answer

The most appropriate initial step is the administration of calcium gluconate via intravenous infusion.
The correct intervention is the administration of intravenous calcium gluconate. This patient is experiencing Tumor Lysis Syndrome (TLS), an oncologic emergency characterized by the massive release of intracellular contents following the initiation of cytotoxic therapy for rapidly proliferating tumors. This results in hyperkalemia, hyperphosphatemia, hyperuricemia, and secondary hypocalcemia. The most life-threatening complication is hyperkalemia, evidenced by his elevated level of 6.86.8 mEq/L and characteristic ECG changes (peaked T waves, prolonged PR interval). The immediate, most critical step in management is myocardial stabilization with intravenous calcium gluconate (or calcium chloride) to raise the threshold potential and prevent fatal ventricular arrhythmias. Once the myocardium is stabilized, subsequent therapies to shift potassium intracellularly (e.g., insulin and glucose) and treat the underlying TLS (e.g., aggressive hydration, rasburicase) should be initiated.

Step-by-Step Solution

1
Analyze the patient's history and current presentation.
A patient with newly treated high-grade lymphoma presents acutely with muscle cramps, arrhythmias, and acute kidney injury.
Recent initiation of cytotoxic chemotherapy in high-grade lymphomas strongly predisposes to massive cellular breakdown.
2
Interpret the laboratory and ECG findings.
Labs show hyperkalemia, hyperuricemia, hyperphosphatemia, and hypocalcemia. ECG shows peaked T waves and prolonged PR interval.
These findings definitively confirm Tumor Lysis Syndrome (TLS) complicated by severe, symptomatic hyperkalemia.
3
Determine the most critical priority in management.
The most immediate threat to the patient's life is a fatal ventricular arrhythmia induced by the hyperkalemia.
While treating the underlying TLS (e.g., hydration, rasburicase) and lowering total body potassium are necessary, stabilizing the cardiac membrane is the most urgent, time-sensitive intervention.

Key Concept

Tumor Lysis Syndrome (TLS) can cause life-threatening hyperkalemia; when accompanied by ECG changes, the immediate priority is myocardial stabilization with intravenous calcium.
Estimated Time:1m 30s
Question 2337Question →

Match the following clinical presentations of patients with advanced HIV infection to the most appropriate initial targeted antimicrobial therapy.

Click a left item, then click its matching right item

Items

An immunocompromised patient (CD4 count = 35 cells/mm335 \text{ cells/mm}^3) complains of seeing 'floating spots' and progressive blurring of vision. Retinal examination demonstrates dense, yellowish-white areas of necrosis accompanied by perivascular hemorrhages.
Following a week of worsening headaches and lethargy, a patient with poorly controlled HIV (CD4 count = 80 cells/mm380 \text{ cells/mm}^3) undergoes a lumbar puncture. The cerebrospinal fluid has a significantly elevated opening pressure and tests positive for a capsular polysaccharide antigen.
A patient with advanced HIV (CD4 count = 150 cells/mm3150 \text{ cells/mm}^3) describes a three-week history of worsening shortness of breath on exertion and a nonproductive cough. High-resolution chest computed tomography reveals diffuse, bilateral ground-glass opacities.
Emergency medical services bring in a patient with known HIV (CD4 count = 40 cells/mm340 \text{ cells/mm}^3) after witnessing a generalized tonic-clonic seizure. Subsequent magnetic resonance imaging of the brain highlights several ring-enhancing lesions located within the basal ganglia.

Matches

Show answer & explanation

Answer

The correct matches are: 1) CMV retinitis matched to Valganciclovir, 2) Cryptococcal meningoencephalitis matched to Liposomal amphotericin B and flucytosine, 3) Pneumocystis jirovecii pneumonia matched to Trimethoprim-sulfamethoxazole, and 4) Toxoplasma encephalitis matched to Sulfadiazine, pyrimethamine, and leucovorin.
Each clinical vignette describes classic pathognomonic findings for specific HIV-related opportunistic infections. CMV retinitis presents with retinal hemorrhages and exudates and is treated with valganciclovir. Cryptococcal meningitis presents with elevated intracranial pressure and positive capsular antigen, requiring induction therapy with liposomal amphotericin B and flucytosine. PJP presents with bilateral ground-glass opacities and is treated with high-dose TMP-SMX. Toxoplasma encephalitis presents with ring-enhancing lesions and seizures, necessitating treatment with sulfadiazine, pyrimethamine, and leucovorin (to prevent pyrimethamine-induced hematologic toxicity).

Step-by-Step Solution

1
Identify the underlying opportunistic infection based on the clinical vignette findings and the patient's CD4 cell count threshold.
Diagnoses identified are CMV retinitis, Cryptococcal meningoencephalitis, Pneumocystis jirovecii pneumonia (PJP), and Toxoplasma gondii encephalitis.
Accurate pathogen identification is required to select the precise targeted antimicrobial therapy.
2
Select the appropriate first-line antimicrobial regimen for each definitively identified pathogen.
Matched each opportunistic infection to its respective gold-standard pharmacotherapy.
Using the correct targeted therapy maximizes clinical efficacy and adheres to established infectious disease guidelines.

Key Concept

Diagnosis and first-line targeted therapy of major opportunistic infections in patients with advanced HIV based on CD4 count thresholds and classic clinical presentations.
Question 2338Question →

A medical student is preparing a comprehensive timeline of preventive care milestones to use during a pediatric clerkship. The student aims to map out the exact age at which specific universal screening tests are first introduced for a healthy, term, asymptomatic pediatric patient with no family history of genetic or metabolic disease. According to the American Academy of Pediatrics (AAP) Bright Futures guidelines, arrange the following universal screening interventions in chronological order based on the age they should FIRST be administered, from earliest to latest.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of first universal screenings is: General developmental screening (9 months), Anemia screening (12 months), Autism screening (18 months), Visual acuity testing (4 years), Dyslipidemia screening (9 to 11 years), and Major depressive disorder screening (12 years).
The American Academy of Pediatrics (AAP) Bright Futures guidelines establish a highly specific timeline for universal screening in asymptomatic children. The sequence begins with general developmental screening at 9 months. At 12 months, universal screening for anemia is indicated. At 18 months, an autism-specific screening tool is introduced. By 4 years of age, children are universally screened for visual acuity using optotype charts. Later in childhood, universal dyslipidemia screening is performed once between 9 and 11 years of age. Finally, universal screening for major depressive disorder begins at 12 years of age.

Step-by-Step Solution

1
Determine the initial age for general developmental screening.
9 months of age.
AAP guidelines recommend the first standardized general developmental screening at 9 months.
2
Determine the initial age for universal anemia screening.
12 months of age.
Term infants are universally screened for iron deficiency anemia via hemoglobin/hematocrit at 12 months, corresponding with the depletion of physiological iron stores and transition to cow's milk.
3
Determine the initial age for autism spectrum disorder screening.
18 months of age.
Autism-specific screening (e.g., M-CHAT) is universally initiated at the 18-month visit.
4
Determine the initial age for visual acuity screening using optotypes.
4 years of age.
Cooperation for visual acuity charts (optotypes) is generally sufficient by age 4, marking the start of this universal screening method.
5
Determine the initial age for universal dyslipidemia screening.
9 to 11 years of age.
A baseline lipid profile is obtained universally during this prepubertal window.
6
Determine the initial age for major depressive disorder screening.
12 years of age.
Annual universal screening for depression formally begins at age 12.

Key Concept

AAP Bright Futures Periodicity Schedule for Universal Pediatric Screening
Estimated Time:1m 30s
Question 2339Question →

A 34-year-old woman is hospitalized for a 3-week history of daily fevers up to 39.8°C (103.6°F), severe polyarthralgia, and a faint, salmon-colored macular rash on her trunk that appears predominantly during febrile episodes. Physical examination reveals cervical lymphadenopathy and mild hepatosplenomegaly. Initial laboratory studies show:

Hemoglobin: 10.2 g/dL
Leukocytes: 18,500/mm³ (85% neutrophils)
Platelets: 450,000/mm³
Erythrocyte sedimentation rate (ESR): 95 mm/h
Ferritin: 8,500 ng/mL

Antinuclear antibody and rheumatoid factor testing are negative. She is started on empiric NSAIDs and corticosteroids for suspected adult-onset Still's disease. Three days later, her condition acutely deteriorates. She becomes lethargic and her temperature remains elevated at 40.1°C (104.2°F). Repeat laboratory studies show:

Hemoglobin: 8.1 g/dL
Leukocytes: 3,200/mm³
Platelets: 45,000/mm³
Erythrocyte sedimentation rate (ESR): 12 mm/h
Aspartate aminotransferase (AST): 450 U/L
Alanine aminotransferase (ALT): 520 U/L
Triglycerides: 480 mg/dL

Which of the following best explains the marked decrease in this patient's erythrocyte sedimentation rate compared to admission?

Show answer & explanation

Answer: Profound depletion of circulating fibrinogen

Answer

The correct answer is profound depletion of circulating fibrinogen.
The correct answer correctly identifies that a profound depletion of circulating fibrinogen is responsible for the rapidly falling ESR. The patient's acute deterioration is classic for Macrophage Activation Syndrome (MAS), a form of secondary hemophagocytic lymphohistiocytosis (HLH) that frequently complicates adult-onset Still's disease. The excessive macrophage activation in MAS leads to a massive cytokine storm and a consumptive coagulopathy characterized by severe hypofibrinogenemia. Because the ESR is highly dependent on fibrinogen to neutralize the negative charge of red blood cells and facilitate rouleaux formation, the acute loss of fibrinogen causes a paradoxical plummet in the ESR, even while the patient's systemic inflammation is peaking.

Step-by-Step Solution

1
Analyze the patient's initial clinical presentation and laboratory findings.
The combination of quotidian fevers, salmon-colored rash, polyarthritis, seronegativity, extreme hyperferritinemia, and elevated ESR supports a diagnosis of adult-onset Still's disease (AOSD).
Establishing the underlying diagnosis provides the context for recognizing specific, disease-associated complications.
2
Evaluate the clinical deterioration three days after admission.
The acute onset of lethargy, persistent high fever, pancytopenia, elevated transaminases, and hypertriglyceridemia strongly indicate the development of Macrophage Activation Syndrome (MAS).
MAS is a form of secondary hemophagocytic lymphohistiocytosis (HLH) and is a life-threatening complication of rheumatologic conditions, most notably systemic juvenile idiopathic arthritis and AOSD.
3
Determine the pathophysiological mechanism behind the paradoxical drop in ESR.
In MAS, massive macrophage activation causes a severe cytokine storm and consumptive coagulopathy, leading to a marked decrease in circulating fibrinogen (hypofibrinogenemia).
The erythrocyte sedimentation rate (ESR) is directly dependent on asymmetric macromolecules, primarily fibrinogen, which coat red blood cells and promote rouleaux formation. When fibrinogen is rapidly consumed in MAS, the ESR precipitously drops to near-normal or low levels despite overwhelming systemic inflammation.

Key Concept

Macrophage activation syndrome (MAS) is a severe complication of adult-onset Still's disease characterized by pancytopenia, hypertriglyceridemia, transaminitis, and hyperferritinemia. Consumptive hypofibrinogenemia classically results in a paradoxical, sharp decrease in the erythrocyte sedimentation rate despite worsening systemic inflammation.
Question 2340Question →

A 6868-year-old man is evaluated on postoperative day 66 following an elective right total hip arthroplasty. He reports new-onset right calf pain and swelling that began this morning. His temperature is 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}), blood pressure is 130/80130/80 mmHg, pulse is 9898/min, and respirations are 1616/min. Physical examination reveals a swollen, tender right calf with mild erythema. Since admission, the patient has been receiving subcutaneous enoxaparin for deep vein thrombosis prophylaxis. Laboratory studies show:

IndicatorValue
Hemoglobin12.412.4 g/dL
Platelet count105,000/μL105,000/\mu\text{L} (Baseline on admission: 260,000/μL260,000/\mu\text{L})
Leukocyte count9,500/μL9,500/\mu\text{L}
Serum creatinine1.11.1 mg/dL

A venous Doppler ultrasound of the right lower extremity confirms an acute deep venous thrombosis in the popliteal vein. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue enoxaparin and initiate argatroban

Answer

Discontinue enoxaparin and initiate argatroban
The correct approach involves immediately stopping all heparin products and starting a non-heparin anticoagulant, such as the direct thrombin inhibitor argatroban. This patient has classic features of Heparin-Induced Thrombocytopenia (HIT) Type 2: a >50%>50\% drop in platelet count occurring 55 to 1010 days after the initiation of a heparin product (enoxaparin), accompanied by a new thrombotic event (DVT). HIT is an immune-mediated disorder caused by IgG antibodies against the heparin-platelet factor 4 (PF4) complex, which activates platelets and triggers widespread thrombosis. Because enoxaparin is the inciting agent, it must be discontinued. However, the patient remains at a very high risk for further life-threatening thromboses, so a non-heparin alternative must be started promptly.

Step-by-Step Solution

1
Analyze the clinical presentation and timing.
Postoperative day 6 patient with a new deep vein thrombosis (DVT) and low-grade fever.
To establish the acute clinical problem requiring management.
2
Evaluate the laboratory findings in context.
Platelet count dropped from 260,000/μL260,000/\mu\text{L} to 105,000/μL105,000/\mu\text{L} (a >50%>50\% decrease) while on enoxaparin.
To identify potential complications of pharmacological prophylaxis.
3
Synthesize findings to formulate a diagnosis.
The timing (5-10 days post-exposure), >50%>50\% platelet drop, and new thrombosis are highly suggestive of Heparin-Induced Thrombocytopenia (HIT) Type 2.
To determine the underlying pathophysiology of the new DVT.
4
Determine the appropriate management for the diagnosis.
All heparin products (including LMWH) must be stopped immediately, and a non-heparin anticoagulant like a direct thrombin inhibitor (e.g., argatroban) must be started.
To prevent further immune-mediated platelet activation and thrombosis.

Key Concept

Diagnosis and management of Heparin-Induced Thrombocytopenia (HIT) Type 2
Estimated Time:1m 30s
PreviousPage 117 / 414Next
All practice questions — USMLE Step 2 CK | Examkin